newsfilter
← Latest News
GlobeNewswire·

Zynerba Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

DEVON, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Arman